Metabolic syndrome: a work in progress, but a useful construct

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2007-04, Vol.115 (13), p.1812-8; discussion 1818
Hauptverfasser: Beaser, Richard S, Levy, Philip
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8; discussion 1818
container_issue 13
container_start_page 1812
container_title Circulation (New York, N.Y.)
container_volume 115
creator Beaser, Richard S
Levy, Philip
description
doi_str_mv 10.1161/CIRCULATIONAHA.106.673616
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_70338586</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70338586</sourcerecordid><originalsourceid>FETCH-LOGICAL-p124t-f4b72e4a5d19cff44055aa7d776f496d8d1f1f6d29fcb57376eab8f1b558623d3</originalsourceid><addsrcrecordid>eNo1j11LwzAYhYMgbk7_gsQbr-zM23y1XgilqBtMB7Jdl6RJpNqPmTSI_96C8-rA4eHhHISugSwBBNyV67dyvyl26-1rsSqWQMRSSCpAnKA58JQljNN8hs5D-CCECCr5GZqBZISBTOfo4cWOSg9tU-Pw0xs_dPYeK_w9-E_c9Pjgh3dvQ7jFOo5TH4N1scX10IfRx3q8QKdOtcFeHnOB9k-Pu3KVbLbP67LYJAdI2Zg4pmVqmeIG8to5xgjnSkkjpXAsFyYz4MAJk-au1lxSKazSmQPNeSZSaugC3fx5p0Ff0Yax6ppQ27ZVvR1iqCShNJvYCbw6glF31lQH33TK_1T_j-kv8phY5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70338586</pqid></control><display><type>article</type><title>Metabolic syndrome: a work in progress, but a useful construct</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Journals@Ovid Complete</source><creator>Beaser, Richard S ; Levy, Philip</creator><creatorcontrib>Beaser, Richard S ; Levy, Philip</creatorcontrib><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.106.673616</identifier><identifier>PMID: 17404172</identifier><language>eng</language><publisher>United States</publisher><subject>Abdominal Fat - physiopathology ; Angiotensin-Converting Enzyme Inhibitors - pharmacology ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Clinical Trials as Topic ; Cohort Studies ; Coronary Disease - etiology ; Diabetes Mellitus, Type 2 - etiology ; Diabetes Mellitus, Type 2 - prevention &amp; control ; Humans ; Hypertension - complications ; Insulin Resistance ; Metabolic Syndrome - complications ; Metabolic Syndrome - diagnosis ; Metabolic Syndrome - physiopathology ; Metabolic Syndrome - therapy ; Models, Biological ; Obesity - complications ; Obesity - physiopathology ; Prognosis ; Risk Factors ; Thiazolidinediones - therapeutic use</subject><ispartof>Circulation (New York, N.Y.), 2007-04, Vol.115 (13), p.1812-8; discussion 1818</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17404172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Beaser, Richard S</creatorcontrib><creatorcontrib>Levy, Philip</creatorcontrib><title>Metabolic syndrome: a work in progress, but a useful construct</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><subject>Abdominal Fat - physiopathology</subject><subject>Angiotensin-Converting Enzyme Inhibitors - pharmacology</subject><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Clinical Trials as Topic</subject><subject>Cohort Studies</subject><subject>Coronary Disease - etiology</subject><subject>Diabetes Mellitus, Type 2 - etiology</subject><subject>Diabetes Mellitus, Type 2 - prevention &amp; control</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Insulin Resistance</subject><subject>Metabolic Syndrome - complications</subject><subject>Metabolic Syndrome - diagnosis</subject><subject>Metabolic Syndrome - physiopathology</subject><subject>Metabolic Syndrome - therapy</subject><subject>Models, Biological</subject><subject>Obesity - complications</subject><subject>Obesity - physiopathology</subject><subject>Prognosis</subject><subject>Risk Factors</subject><subject>Thiazolidinediones - therapeutic use</subject><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j11LwzAYhYMgbk7_gsQbr-zM23y1XgilqBtMB7Jdl6RJpNqPmTSI_96C8-rA4eHhHISugSwBBNyV67dyvyl26-1rsSqWQMRSSCpAnKA58JQljNN8hs5D-CCECCr5GZqBZISBTOfo4cWOSg9tU-Pw0xs_dPYeK_w9-E_c9Pjgh3dvQ7jFOo5TH4N1scX10IfRx3q8QKdOtcFeHnOB9k-Pu3KVbLbP67LYJAdI2Zg4pmVqmeIG8to5xgjnSkkjpXAsFyYz4MAJk-au1lxSKazSmQPNeSZSaugC3fx5p0Ff0Yax6ppQ27ZVvR1iqCShNJvYCbw6glF31lQH33TK_1T_j-kv8phY5A</recordid><startdate>20070403</startdate><enddate>20070403</enddate><creator>Beaser, Richard S</creator><creator>Levy, Philip</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20070403</creationdate><title>Metabolic syndrome: a work in progress, but a useful construct</title><author>Beaser, Richard S ; Levy, Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p124t-f4b72e4a5d19cff44055aa7d776f496d8d1f1f6d29fcb57376eab8f1b558623d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Abdominal Fat - physiopathology</topic><topic>Angiotensin-Converting Enzyme Inhibitors - pharmacology</topic><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Clinical Trials as Topic</topic><topic>Cohort Studies</topic><topic>Coronary Disease - etiology</topic><topic>Diabetes Mellitus, Type 2 - etiology</topic><topic>Diabetes Mellitus, Type 2 - prevention &amp; control</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Insulin Resistance</topic><topic>Metabolic Syndrome - complications</topic><topic>Metabolic Syndrome - diagnosis</topic><topic>Metabolic Syndrome - physiopathology</topic><topic>Metabolic Syndrome - therapy</topic><topic>Models, Biological</topic><topic>Obesity - complications</topic><topic>Obesity - physiopathology</topic><topic>Prognosis</topic><topic>Risk Factors</topic><topic>Thiazolidinediones - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beaser, Richard S</creatorcontrib><creatorcontrib>Levy, Philip</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beaser, Richard S</au><au>Levy, Philip</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolic syndrome: a work in progress, but a useful construct</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2007-04-03</date><risdate>2007</risdate><volume>115</volume><issue>13</issue><spage>1812</spage><epage>8; discussion 1818</epage><pages>1812-8; discussion 1818</pages><eissn>1524-4539</eissn><cop>United States</cop><pmid>17404172</pmid><doi>10.1161/CIRCULATIONAHA.106.673616</doi></addata></record>
fulltext fulltext
identifier EISSN: 1524-4539
ispartof Circulation (New York, N.Y.), 2007-04, Vol.115 (13), p.1812-8; discussion 1818
issn 1524-4539
language eng
recordid cdi_proquest_miscellaneous_70338586
source MEDLINE; American Heart Association Journals; EZB-FREE-00999 freely available EZB journals; Journals@Ovid Complete
subjects Abdominal Fat - physiopathology
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Clinical Trials as Topic
Cohort Studies
Coronary Disease - etiology
Diabetes Mellitus, Type 2 - etiology
Diabetes Mellitus, Type 2 - prevention & control
Humans
Hypertension - complications
Insulin Resistance
Metabolic Syndrome - complications
Metabolic Syndrome - diagnosis
Metabolic Syndrome - physiopathology
Metabolic Syndrome - therapy
Models, Biological
Obesity - complications
Obesity - physiopathology
Prognosis
Risk Factors
Thiazolidinediones - therapeutic use
title Metabolic syndrome: a work in progress, but a useful construct
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T18%3A32%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolic%20syndrome:%20a%20work%20in%20progress,%20but%20a%20useful%20construct&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=Beaser,%20Richard%20S&rft.date=2007-04-03&rft.volume=115&rft.issue=13&rft.spage=1812&rft.epage=8;%20discussion%201818&rft.pages=1812-8;%20discussion%201818&rft.eissn=1524-4539&rft_id=info:doi/10.1161/CIRCULATIONAHA.106.673616&rft_dat=%3Cproquest_pubme%3E70338586%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70338586&rft_id=info:pmid/17404172&rfr_iscdi=true